Annual Gross Margin
31.05%
-4.54%-12.76%
31 December 2023
Summary:
Emergent BioSolutions annual gross profit margin is currently 31.05%, with the most recent change of -4.54% (-12.76%) on 31 December 2023. During the last 3 years, it has fallen by -32.22% (-50.92%). EBS annual gross margin is now -63.12% below its all-time high of 84.20%, reached on 31 December 2006.EBS Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
56.80%
+76.15%+393.54%
30 September 2024
Summary:
Emergent BioSolutions quarterly gross profit margin is currently 56.80%, with the most recent change of +76.15% (+393.54%) on 30 September 2024. Over the past year, it has increased by +23.77% (+71.96%). EBS quarterly gross margin is now -39.73% below its all-time high of 94.24%, reached on 31 March 2011.EBS Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.8% | +72.0% |
| 3 y3 years | -50.9% | +87.4% |
| 5 y5 years | -42.8% | -6.7% |
EBS Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -50.9% | at low | -16.3% | +393.5% |
| 5 y | 5 years | -50.9% | at low | -17.8% | +393.5% |
| alltime | all time | -63.1% | at low | -39.7% | +393.5% |
Emergent BioSolutions Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 56.80%(-393.5%) |
| June 2024 | - | -19.35%(-138.3%) |
| Mar 2024 | - | 50.55%(+60.9%) |
| Dec 2023 | 31.05%(-12.8%) | 31.42%(-4.9%) |
| Sept 2023 | - | 33.03%(-22.2%) |
| June 2023 | - | 42.47%(+1265.6%) |
| Mar 2023 | - | 3.11%(-90.2%) |
| Dec 2022 | 35.59%(-34.5%) | 31.75%(-6.2%) |
| Sept 2022 | - | 33.84%(+21.4%) |
| June 2022 | - | 27.87%(-41.5%) |
| Mar 2022 | - | 47.67%(-29.8%) |
| Dec 2021 | 54.37%(-14.1%) | 67.88%(+124.0%) |
| Sept 2021 | - | 30.31%(-21.8%) |
| June 2021 | - | 38.78%(-43.9%) |
| Mar 2021 | - | 69.13%(+2.1%) |
| Dec 2020 | 63.27%(+13.1%) | 67.73%(+15.7%) |
| Sept 2020 | - | 58.53%(-10.0%) |
| June 2020 | - | 65.02%(+18.8%) |
| Mar 2020 | - | 54.74%(-9.5%) |
| Dec 2019 | 55.92%(+3.0%) | 60.50%(-0.7%) |
| Sept 2019 | - | 60.90%(+21.4%) |
| June 2019 | - | 50.15%(+9.9%) |
| Mar 2019 | - | 45.65%(-14.7%) |
| Dec 2018 | 54.31%(-12.0%) | 53.54%(-3.4%) |
| Sept 2018 | - | 55.41%(-4.7%) |
| June 2018 | - | 58.12%(+24.4%) |
| Mar 2018 | - | 46.71%(-28.1%) |
| Dec 2017 | 61.73%(-2.7%) | 64.99%(-2.4%) |
| Sept 2017 | - | 66.59%(+17.7%) |
| June 2017 | - | 56.60%(+5.8%) |
| Mar 2017 | - | 53.49%(-21.4%) |
| Dec 2016 | 63.43%(-10.8%) | 68.05%(+5.5%) |
| Sept 2016 | - | 64.49%(+30.0%) |
| June 2016 | - | 49.62%(-25.2%) |
| Mar 2016 | - | 66.36%(-10.9%) |
| Dec 2015 | 71.10% | 74.50%(+2.5%) |
| Sept 2015 | - | 72.65%(+3.8%) |
| June 2015 | - | 70.00%(+81.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | 38.60%(-53.4%) |
| Dec 2014 | 67.40%(-11.2%) | 82.75%(+26.4%) |
| Sept 2014 | - | 65.47%(+8.1%) |
| June 2014 | - | 60.54%(+19.5%) |
| Mar 2014 | - | 50.65%(-34.5%) |
| Dec 2013 | 75.91%(-3.5%) | 77.33%(+4.9%) |
| Sept 2013 | - | 73.70%(-0.6%) |
| June 2013 | - | 74.17%(-8.7%) |
| Mar 2013 | - | 81.23%(+2.0%) |
| Dec 2012 | 78.66%(-0.6%) | 79.62%(-1.8%) |
| Sept 2012 | - | 81.06%(+7.8%) |
| June 2012 | - | 75.20%(-3.8%) |
| Mar 2012 | - | 78.14%(+27.6%) |
| Dec 2011 | 79.17%(-2.6%) | 61.25%(-25.1%) |
| Sept 2011 | - | 81.78%(+0.0%) |
| June 2011 | - | 81.77%(-13.2%) |
| Mar 2011 | - | 94.24%(+25.4%) |
| Dec 2010 | 81.26%(+1.2%) | 75.17%(-10.9%) |
| Sept 2010 | - | 84.41%(+2.7%) |
| June 2010 | - | 82.18%(-2.1%) |
| Mar 2010 | - | 83.96%(+7.5%) |
| Dec 2009 | 80.30%(-0.8%) | 78.10%(-2.3%) |
| Sept 2009 | - | 79.93%(-6.8%) |
| June 2009 | - | 85.75%(+12.6%) |
| Mar 2009 | - | 76.18%(-5.7%) |
| Dec 2008 | 80.91%(+3.8%) | 80.78%(-0.8%) |
| Sept 2008 | - | 81.41%(+1.7%) |
| June 2008 | - | 80.03%(-1.5%) |
| Mar 2008 | - | 81.25%(+1.0%) |
| Dec 2007 | 77.96%(-7.4%) | 80.43%(+8.9%) |
| Sept 2007 | - | 73.86%(-1.3%) |
| June 2007 | - | 74.80%(-5.5%) |
| Mar 2007 | - | 79.14%(-7.6%) |
| Dec 2006 | 84.20%(+11.1%) | 85.64%(+3.5%) |
| Sept 2006 | - | 82.75% |
| Dec 2005 | 75.82%(+18.6%) | - |
| Dec 2004 | 63.95%(-6.9%) | - |
| Dec 2002 | 68.72% | - |
FAQ
- What is Emergent BioSolutions annual gross profit margin?
- What is the all time high annual gross margin for Emergent BioSolutions?
- What is Emergent BioSolutions annual gross margin year-on-year change?
- What is Emergent BioSolutions quarterly gross profit margin?
- What is the all time high quarterly gross margin for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly gross margin year-on-year change?
What is Emergent BioSolutions annual gross profit margin?
The current annual gross margin of EBS is 31.05%
What is the all time high annual gross margin for Emergent BioSolutions?
Emergent BioSolutions all-time high annual gross profit margin is 84.20%
What is Emergent BioSolutions annual gross margin year-on-year change?
Over the past year, EBS annual gross profit margin has changed by -4.54% (-12.76%)
What is Emergent BioSolutions quarterly gross profit margin?
The current quarterly gross margin of EBS is 56.80%
What is the all time high quarterly gross margin for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly gross profit margin is 94.24%
What is Emergent BioSolutions quarterly gross margin year-on-year change?
Over the past year, EBS quarterly gross profit margin has changed by +23.77% (+71.96%)